The incidence of V˙O2 plateau at V˙O2max in a cardiac-diseased population

We sought to determine the incidence of V˙O(2) plateau at V˙O(2)max in a cardiovascular-diseased (CVD) population using 4 different sampling intervals (15-breath moving average, 15 s, 30 s, and 60 s) and 3 different V˙O(2) plateau criteria (≤50 mL · min(-1), ≤80 mL · min(-1), and ≤150 mL · min(-1)). A total of 69 people (62 ± 10 yrs.) with recently diagnosed CVD performed a maximal exercise test (10:07 ± 2:24 min) on a treadmill. The test was classified as maximal (n = 57, 2 430 ± 605 mL · min(-1)) if self-terminated due to fatigue or classified as symptom-limited (n = 12, 1 683 ± 438 mL · min(-1)) if symptoms presented. Chi-square analysis revealed a significant (p < 0.05) effect of sampling interval on incidence of V˙O(2) plateau at V˙O(2)max across all 3 V˙O(2) plateau criteria. The sampling interval had an increasingly stronger influence on the incidence of V˙O(2) plateau at V˙O(2)max with smaller criterion thresholds as evidenced by the Cramer\u27s V statistics: [≤50 mL · min(-1) (Cramer\u27s V = 0.548, p < 0.05], ≤80 mL · min(-1) [Cramer\u27s V = 0.489, p < 0.05], ≤150 mL · min(-1) [Cramer\u27s V = 0.214, p < 0.05]. Incidence of V˙O(2) plateau at V˙O(2)max in CVD individuals is significantly influenced by the sampling interval applied. Based on our findings we recommend a15 breath moving average and V˙O(2) plateau criterion of ≤50 mL · min(-1)